sAPPα, the non-amyloidogenic product of ADAM10, has been well characterized for its neuroprotective roles and its therapeutic potentials in Alzheimer’s disease [52]. The gene discussed is ADAM10; the disease is early-onset autosomal dominant Alzheimer disease.